NPPA notified regarding the computation of the retail price of Dapagliflozin Propanediol USP eq to Dapagliflozin IP 10mg + Metoprolol Succinate IP 23.75mg eq to Metoprolol Tartrate 25mg (as extended release) for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Cipla Limited (Marketer)

Mar 04, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal" style="text-align: justify;">The National Pharmaceutical Pricing Authority (NPPA) on March 03, 2025, notified regarding the computation of the retail price of Dapagliflozin Propanediol USP eq to Dapagliflozin IP 10mg + Metoprolol Succinate IP 23.75mg eq to Metoprolol Tartrate 25mg (as extended release) for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Cipla Limited (Marketer).

 

It states that the price of each film coated bilayer tablet containing:- Dapagliflozin Propanediol USP eq to Dapagliflozin IP 10mg + Metoprolol Succinate IP 23.75mg eq to Metoprolol Tartrate 25mg (as extended release) for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Cipla Limited (Marketer) has been revised to Rs. 15.96/-.


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT